In a previously published study including 75 PC patients at disease recurrence after local therapy, BChE activity below 300 U/L was identified as an independent prognostic marker in multivariate analysis in patients without peritoneal dissemination. This evidence concerns the gene BCHE and pachyonychia congenita.